EX-99.1 2 ex99-1.htm EX-99.1

 

Exhibit 99.1

 

THARIMMUNE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   August 31, 2025 
   (Unaudited) 
      
ASSETS     
      
Current assets     
Cash and cash equivalents  $8,782,667 
Prepaid expenses and other current assets   151,591 
Deferred offering costs   92,168 
      
Total current assets   9,026,426 
      
Total assets  $9,026,426 
      
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)     
      
Current liabilities     
Accounts payable  $870,296 
Accrued expenses   1,046,057 
Insurance premium financing liability   49,599 
Note payable   184,139 
      
Total current liabilities   2,150,091 
      
Total liabilities   2,150,091 
      
Stockholders’ equity     

Preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of August 31, 2025

   - 

Common stock, $0.0001 par value, 250,000,000 shares authorized, 6,809,460 shares issued and 6,809,214 shares outstanding as of August 31, 2025, respectively

   681 
Additional paid-in capital   49,095,404 
Accumulated deficit   (42,149,785)
Treasury stock, at cost, 246 shares held in treasury as of August 31, 2025   (69,965)
      
Total stockholders’ equity   6,876,335 
      
Total liabilities and stockholders’ equity  $9,026,426